Related Experiment Video
Updated: Jul 19, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Predictive markers of pituitary adenoma behavior
1Department of Pathology and Pituitary Tumor Reference Center, G. Gennimatas General Hospital of Athens, Athens, Greece. gkonto@med.uoa.gr
Neuroendocrinology
|October 19, 2006
Summary
Predicting pituitary tumor behavior relies on key markers like tumor invasiveness and Ki-67 labeling index. Apoptosis, p53 expression, and somatostatin receptor assessment also offer crucial prognostic information for clinicians.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Pathologists aim to predict tumor biology for clinicians.
- Morphologic features are crucial for predicting tumor behavior and prognosis.
- Tumor invasiveness and proliferation markers are key indicators.
Purpose of the Study:
- To identify and evaluate key predictive factors for pituitary adenomas.
- To assess the prognostic significance of various morphologic and molecular markers.
- To guide clinical management through accurate tumor characterization.
Main Methods:
- Morphologic assessment including mitoses and invasion.
- Ki-67 labeling index (LI) for proliferation.
- p53 expression analysis.
- Apoptosis detection using DNA labeling.
- Cytogenetic analysis (chromosome 11).
- Immunohistochemistry for somatostatin receptors.
Main Results:
- Tumor invasiveness is a consistent prognostic indicator.
- Ki-67 LI and p53 expression are vital for classifying atypical adenomas.
- Higher apoptotic LI observed in functioning, microadenomas, and untreated adenomas.
- Chromosome 11 abnormalities correlate with functioning, aneuploid adenomas.
- Somatostatin receptor density predicts treatment response to analogues.
Conclusions:
- Tumor invasiveness, mitoses, Ki-67 LI, p53 expression, and apoptosis are important prognostic factors.
- Cytogenetic analyses are valuable but complex to apply.
- Immunohistochemistry for somatostatin receptors shows future promise for predicting treatment efficacy.
